Dr. Anand Sachithanandan—Kuala Lumpur Dr. Anand Sachithanandan is a consultant cardiothoracic surgeon in private practice in greater Kuala Lumpur. He is co-founder and president of Lung Cancer Network Malaysia, an […] Read more
Dr. Narjust Duma—USA Dr. Narjust Duma is a member of the UW Carbone Cancer Center and Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care. […] Read more
Janet Freeman-Daily—USA Janet is a retired aerospace systems engineer, freelance writer, and metastatic lung cancer patient/activist. Diagnosed in 2011, her focus is now on translating the experience and science of […] Read more
After careful consideration of the current situation, the IASLC Board of Directors and leadership have made the decision to postpone the IASLC 2020 World Conference on Lung Cancer (WCLC 2020), […] Read more
Déjà Vu, With a Twist: The Vaping Industry’s Approach to Youth-Oriented Advertising Via Social Media
Posted: February 12, 2020 Dr. Lisa Fucito As of early December 2019, the Centers for Disease Control and Prevention (CDC) have received reports from all 50 states, Puerto Rico, the […] Read more
Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s Perspective
By Lynette M. Sholl, MD, and John W. Longshore, PhD, FACMG Posted: February 12, 2020 Dr. Lynette M. Sholl Dr. John W. Longshore The profound impact of immunotherapy in patients […] Read more
Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC
By Youquan Li, MD, FRCR, and Andrea Bezjak, MDCM, MSc, FRCPC Posted: February 12, 2020 Targeted agents including TKIs of EGFR, ALK, and ROS1 have significantly improved the outcomes of […] Read more
Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia
Posted: February 12, 2020 Ravi Salgia, MD, PhD, is the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology and the associate director for clinical sciences at City of Hope’s […] Read more
By Alexander Drilon, MD Posted: February 12, 2020 The receptor tyrosine kinases TRKA/B/C are encoded by the genes NTRK1/2/3. TRK fusions are oncogenic drivers of various adult and pediatric cancers. […] Read more
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr. Edgardo S. Santos Castillero
Posted: February 12, 2020 Edgardo S. Santos Castillero, MD, FACP, is an IASLC Lung Cancer News Editorial Group Member and served as a co-chair on the expert panel that developed […] Read more